Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-29

Clinical Trial Update: Phase II Study to Assess Safety and Efficacy of SL-1002 for Osteoarthritic Knee Pain [Phase 2]

View source ↗

Summary

Phase II study update for SL-1002 evaluating safety and efficacy in osteoarthritis-related knee pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SL-1002

Snippet

Sponsor: Saol Therapeutics Inc | Conditions: Osteoarthritis, Knee Pain | Phase 2 | Status: UNKNOWN